PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29031923-0	2018	DEAE-Dextran coated paclitaxel nanoparticles act as multifunctional nano system for intranuclear delivery to triple negative breast cancer through VEGF and NOTCH1 inhibition.	DEAE-Dextran	0-12	vascular endothelial growth factor A	Homo sapiens	147-151	
29311933-0	2017	Role of beta-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction.	DEAE-Dextran	33-45	vascular endothelial growth factor A	Homo sapiens	67-71	
29311933-7	2017	Anti-angiogenic property of DEAE-Dextran was concluded by the downregulation of CD31, VEGF, and NOTCH1 both in vivo and in vitro.	DEAE-Dextran	28-40	vascular endothelial growth factor A	Homo sapiens	86-90	
29311933-9	2017	Overall, results are defensive of DEAE-Dextran as an emerging anti-tumor agent with mechanisms pertaining to beta-interferon induction with probable VEGF and NOTCH1 inhibition as well as apoptosis which still needs to be studied in further depth.	DEAE-Dextran	34-46	vascular endothelial growth factor A	Homo sapiens	149-153